Asia Morning: Dow Adds 2% on Continued Reopening Optimism

On Tuesday U.S. stocks were mostly higher, boosted by the potential development of a coronavirus vaccine and further easing of lockdown measures in the U.S. and around the world...

Trading floor 2

On Tuesday U.S. stocks were mostly higher, boosted by the potential development of a coronavirus vaccine and further easing of lockdown measures in the U.S. and around the world. Biotechnology firm Novavax (NVAX +4.47%) said on Monday it has started the Phase 1 clinical trial of a novel coronavirus vaccine candidate, making it one of at least 10 now being tested in people globally.

Japan's government lifted the coronavirus-induced state of emergency that had been in place since April. 

The Dow Jones Industrial Average gained 530 points (+2.2%) to 24995, the S&P 500 rose 36 points (+1.2%) to 2991, while the Nasdaq 100 eased 24 points (-0.3%) to 9390.

Source: GAIN Capital, TradingView

Banks (+7.86%), Automobiles & Components (+4.7%) and Capital Goods (+4.41%) sectors were market leaders.

Macy’s (M +18.43%), Alliance Data Systems (ADS +17.53%), United Airlines (UAL +16.30%), TripAdvisor (TRIP +15.57%) and Norwegian Cruise Line (NCLH +15.32%) were top gainers. On the other hand, Take-Two Interactive Software (TTWO -7.34%), Newmont Goldcorp (NEM -6.09%) and Regeneron Pharmaceuticals (REGN -4.33%) lost the most.  

On the technical side, about 33.6% (32.0% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average, and 66.3% (65.7% in the prior session) were above their 20-day moving average.
U.S. official data showed that New Home Sales rose to an annualized rate of 623,000 in April (a decline to 480,000 units expected). The Conference Board's Consumer Confidence Index increased to 86.6 in May (87.0 expected).

Later today, the U.S. Federal Reserve will release its Beige Book economic report.

European stocks were broadly higher, with the Stoxx Europe 600 Index advancing 1.1%. Germany's DAX gained 1.0%, France's CAC jumped 1.5%, and the U.K. market was up 1.2%.

Spot gold price lost $16 (-0.9%) to $1,710 an ounce posting a two-day decline.

Oil prices regained strength on expectations of rising demand amid re-opening economies. U.S. WTI crude oil futures (July) increased 3.3% to $34.35 a barrel.

On the forex front, the ICE U.S. Dollar Index slid 0.7% on year to a three-week low of 99.01. Federal Reserve Bank of St. Louis President James Bullard said he expects the U.S. economy to recover strongly in the third quarter, with jobless rate dropping below 10% by the year-end.

EUR/USD advanced 0.8% to 1.0983. Germany's GfK Consumer Confidence Index bounced to -18.9 for June (-18.0 expected) from -23.1 in May.

Build your confidence risk free
Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.